nach oben

Urolithiasis

Erschienen in:

01.12.2005 | Original Paper

Influence of estrus status on urinary chemical parameters related to urolithiasis

verfasst von: Yuji Kato, Satoshi Yamaguchi, Hidehiro Kakizaki, Sunao Yachiku

Erschienen in: Urolithiasis | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

The present study examines the urinary chemical parameters related to urolithiasis in healthy female volunteers during premenopause and menopause, and discusses the role of menopause in stone formation. We investigated 24-h urine parameters associated with urinary stones and focused upon estrus status. Participants comprised 30 healthy women, 15 childless, premenopausal women and 15 menopausal women without a history of urolithiasis. Our results showed that menopausal women have lower citrate and higher calcium excretion, which might enhance calcium stone crystallization. We propose that the estrus status of female patients should be considered when evaluating metabolic abnormalities.

Robertson W, Peacock M, Heyburn PJ, Hanes FA (1980) Epidemiological risk factors in calcium stone disease. Scand J Urol Nephrol [Suppl] 53: 15

Lee YH, Huang WC, Chiang H, Chen MT, Huang JK, Chang LS (1992) Determinant role of testosterone in the pathogenesis of urolithiasis in rats. J Urol 147: 1134PubMed

Lee YH, Huang WC, Huang JK, Chang LS (1996) Testosterone enhances whereas estrogen inhibits calcium oxalate stone formation in ethylene glycol treated rats. J Urol 156: 502CrossRefPubMed

Yagisawa T, Ito F, Osaka Y, Amano H, Kobayashi C, Toma H (2001) The influence of sex hormones on renal osteopontin expression and urinary constituents in experimental urolithiasis. J Urol 166: 1078CrossRefPubMed

Hesse A, Klocke K, Classen A, Vahlensieck W (1987) Age and sex as factors in oxalic acid excretion in healthy persons and calcium oxalate stone patients. Contrib Nephrol 58: 16PubMed

Iguchi M, Takamura C, Umekawa T, Kurita T, Kohri K (1999) Inhibitory effects of female sex hormones on urinary stone formation in rats. Kidney Int 56: 479CrossRefPubMed

Nordin BEC, Need AG, Morris HA, Horowitz M (1999) Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporosis Int 9: 351CrossRef

Gallagher JC, Young MN, Nordin BEC (1972) Effect of artificial menopause on plasma and urine calcium and phosphate. Clin Endocrinol 1: 57

Parks JH, Coe FL (1986) A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30: 85PubMed

10.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290PubMed

11.

Kato Y, Yamaguchi S, Yachiku S, Nakazono S, Hori J, Wada N, Hou K (2004) Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis. Urology 63: 7CrossRefPubMed

12.

Tiselius HG (1997) Estimated levels of supersaturation with calcium phosphate and calcium oxalate in the distal tubule. Urol Res 25: 153CrossRefPubMed

13.

Shorr E, Bernheim AR, Taussky H (1942) The relation of urinary citric acid excretion to the menstrual cycle and the steroidal reproductive hormones. Science 95: 606

14.

Iguchi M, Kataoka K, Kohri K, Yachiku S, Kurita T (1981) Investigation of the cases of urolithiasis. The influence of menstrual cycle on the excretion of citric acid and electrolytes. Jpn J Urol 72: 856

15.

Sarada B, Satyanarayana U (1991) Urinary composition in men and women and the risk of urolithiasis. Clin Biochem 24: 487CrossRefPubMed

16.

Yagisawa T, Hayashi T, Yoshida A, Kobayashi C, Okuda H, Ishikawa N, Toma H (2000) Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender. Eur Urol 38: 297CrossRefPubMed

17.

Alpern RJ, Sakhaee K (1997) The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis 29: 291PubMed

18.

Chen SM, Chung LC, Lee YH, Young TK (1991) Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis. J Formos Med Assoc 90: 41PubMed

19.

Yagisawa T, Hayashi T, Yoshida A, Okuda H, Kobayashi H, Ishikawa N, Goya N, Toma H (1999) Metabolic characteristics of the elderly with recurrent calcium oxalate stones. BJU Int 83: 924CrossRefPubMed

20.

Yoshihara H, Yamaguchi S, Yachiku S (1999) Effect of sex hormones on oxalate-synthesizing enzymes in male and female rat liver. J Urol 161: 668CrossRefPubMed

21.

Fan J, Chandhoke PS, Grampsas SA (1999) Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol 10: S376PubMed

22.

Hall WD, Pettinger M, Oberman AL, Watts NB, Johnson KC, Paskett ED, Limacher MC, Hays J (2001) Risk factors for kidney stones in older women in the southern United States. Am J Med Sci 322: 12CrossRefPubMed

23.

Mattix Kramer HJ, Grodstein F, Stampfer MJ, Curhan GC (2003) Menopause and postmenopausal hormone use and risk of incident kidney stones. J Am Soc Nephrol 14: 1272CrossRefPubMed

24.

Dey J, Creighton A, Lindberg JS, Fuselier HA, Kok DJ, Cole FE, Hamm LL (2002) Estrogen replacement increased the citrate and calcium excretion rates in postmenopausal women with recurrent urolithiasis. J Urol 167: 169CrossRefPubMed

25.

Heller HJ, Sakhaee K, Moe OW, Pak CYC (2002) Etiological role of estrogen status in renal stone formation. J Urol 168: 1923CrossRefPubMed

26.

McKane WR, Khosla S, Burritt MF, Kao PC, Wilson DM, Ory SJ, Riggs BL (1995) Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause: a clinical research center study. J Clin Endocrinol Metab 80: 3458CrossRefPubMed

27.

Reginster JY, Christiansen C, Dequinze B, Deroisy R, Gaspard U, Taquet AN, Franchimont P (1993) Effect of transdermal 17 beta-estradiol and oral conjugated equine estrogens on biochemical parameters of bone resorption in natural menopause. Calcif Tissue Int 53: 13CrossRefPubMed

28.

Writing Group for the Women’s Health Initiative Investigators (2002) Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288: 321CrossRefPubMed

29.

Million Women Study Collaborators (2003) Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362: 419CrossRefPubMed

30.

Maroclo MVO, Pereira SD, Sampaio FJB, Cardoso LEM (2005) Urinary glycosaminoglycan excretion during the menstrual cycle in normal young women. J Urol 173: 1789CrossRefPubMed

Titel: Influence of estrus status on urinary chemical parameters related to urolithiasis
verfasst von: Yuji Kato
Satoshi Yamaguchi
Hidehiro Kakizaki
Sunao Yachiku
Publikationsdatum: 01.12.2005
Verlag: Springer-Verlag
Erschienen in: Urolithiasis / Ausgabe 6/2005
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI: https://doi.org/10.1007/s00240-005-0511-5

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Influence of estrus status on urinary chemical parameters related to urolithiasis

Abstract

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2005

Changes in the urine composition during its passage through the ureter. A concept of urothelial function

Viewing windows do not alter Hounsfield units in CT scans

Complications of the upper urinary tract in patients with spinal cord injury: a long-term follow-up study

An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor

Ureteroscopic treatment of ureteral lithiasis with pneumatic lithotripsy: analysis of 287 procedures in a public hospital

The potency of KUL-7211, a selective ureteral relaxant, in isolated canine ureter: comparison with various spasmolytics

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie